The move follows the increase in prices of the drug. Prior to yesterday's approval of the product by the National Drug Authority, the drug was being sold on the open market for an average of 10,000. Shillings. But this price went up fivefold, selling for as much as 50,000 Shillings as the demand went up across the country.
In 2017, a report by the Ministry of Water and Environment on disasters mapped Gulu City among the areas in Northern Uganda, which are potentially prone to floods. As a result, the former Gulu Municipal Council recommended the widening of the banks of Pece Stream and secured the funding from Fichtner, two years ago.
Uganda has registered 29,172 positive cases in the past month according to John Hopkins University coronavirus resource center which is 40% of Uganda’s total cases since start of the pandemic in March, 2020.
According to experts, poor funding and the placing of vaccine orders late has left Uganda in a fix where it might not be able to procure vaccines to vaccinate the critical number of citizens for the whole nation to be safe. They say at the moment Uganda can only vaccinate a few of it's people using donated vaccines rather than procured ones
According to the President, it is important for Uganda not to depend on anyone during its response to the COVID-19 pandemic. The country has two potential therapeutics and vaccine research taking place
According to a statement issued by Prof Patrick Engeu Ogwang, a lecturer at Mbarara University of Science and Technology and also the founder of the drug, no clinical studies have been carried out on the drug to determine its efficacy. As such it is not clear whether it can cure COVID-19
With no clear standards for quality solar panels on the market, Brenda Akankunda, a researcher and Energy Economist at Makerere University Business School (MUBS), says the public is misled into buying solar products that don’t fit the hype attached to them.